AI-Driven Discovery Will Advance Biologic Drug Development
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
05 May 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$4.00
35.8% undervalued intrinsic discount15 Aug
US$2.57
1Y
216.5%7D
27.2%